Delivery Order 75N93024D00017-75N93026F00001
Award Date 7/15/24
Potential Completion Date 7/14/31
Potential Value $1.9M
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20810, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Pharmacology Discovery Services Taiwan, LTD. on January 22, 2021, with a ceiling value of $336,528 for murine models of urinary tract infection caused by antibiotic-resistant bacteria, ultimately completed January 24, 2022. The order was issued under the NIAID Preclinical Models of Infectious Diseases 2017-2024 IDIQ contract. Work was performed in Taiwan under firm fixed price terms. The order required...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Pharmacology Discovery Services Taiwan, LTD. on July 19, 2023, with a ceiling value of $1,193,205 to exercise Option 5B under the NIAID Preclinical Models of Infectious Diseases 2017-2024 IDIQ contract for murine models of antibiotic-resistant urinary tract infection. Ultimate completion date is February 27, 2025. Place of performance is Taiwan. The order is priced on a firm fixed price basis and carries no...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Pharmacology Discovery Services Taiwan, LTD. on September 6, 2018, with a ceiling value of $1,797,620 under the NIAID Preclinical Models of Infectious Diseases 2017-2024 IDIQ for Task A25, exercising Options A, B, and C to provide preclinical models of infectious diseases. Place of performance is St Charles, MO. The order is firm fixed price with an ultimate completion date of September 14, 2019. The delivery...
- The National Institute of Allergy and Infectious Diseases issued a $754,505 delivery order to Pharmacology Discovery Services Taiwan, LTD. on July 10, 2024, under the NIAID Preclinical Models of Infectious Diseases 2017-2024 indefinite-delivery/indefinite-quantity contract for testing in murine models of bacterial infection. Place of performance is Taiwan. The order was priced firm fixed price with an ultimate completion date of July 9, 2025. The NIAID IDIQ contract supports preclinical...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Pharmacology Discovery Services Taiwan, LTD. on July 22, 2026, for mouse models of Neisseria gonorrhoeae infection and preclinical models of infectious diseases, with a ceiling value of $621,336. The order is issued under the Pre-Clinical Models of Infectious Diseases IDIQ, a single-award indefinite-delivery contract vehicle valued up to $146.3 million and running through July 2031. The contract supports NIAID's...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Pharmacology Discovery Services Taiwan, LTD. on May 16, 2022, with a ceiling value of $288,577, under the NIAID Preclinical Models of Infectious Diseases 2017-2024 IDIQ for preclinical infectious disease research services. Place of performance is Taiwan. The order was administratively closed on May 17, 2023, following de-obligation of remaining funds. Work under the parent IDIQ involves designing and supplying...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Pharmacology Discovery Services Taiwan, LTD. on August 31, 2023, under the NIAID Preclinical Models of Infectious Diseases 2017-2024 IDIQ for pre-clinical models of infectious disease, with a ceiling value of $1,239,019. The order is firm fixed price. Place of performance is Taiwan. The ultimate completion date is February 7, 2025. The IDIQ vehicle supports preclinical infectious disease research by providing...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Pharmacology Discovery Services Taiwan, LTD. on August 3, 2018, under the NIAID Preclinical Models of Infectious Diseases 2017-2024 IDIQ, with a ceiling value of $1,272,675 to exercise options 1, 2, and 5 for therapeutic testing in murine models of bacterial thigh and lung infections as preclinical models of infectious diseases. Place of performance is St Charles, MO. The order is firm fixed price with an...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Pharmacology Discovery Services Taiwan, LTD. on August 10, 2021, with a ceiling value of $1.747930 million, under the NIAID Preclinical Models of Infectious Diseases 2017-2024 IDIQ for preclinical models of bacterial infection and therapeutic testing in murine models. The IDIQ supports development and supply of advanced animal models for screening and evaluating medical countermeasures including therapeutics,...
- The National Institute of Allergy and Infectious Diseases issued a $1.87 million delivery order to Pharmacology Discovery Services Taiwan, LTD. on July 12, 2024, under the NIAID Preclinical Models of Infectious Diseases 2017-2024 IDIQ for development and supply of a mouse model of Neisseria gonorrhoeae infection. The NIAID Preclinical Models of Infectious Diseases IDIQ supports preclinical infectious disease research by providing animal and animal replacement models for screening and...